Skip to main content
SpringerLink
Log in
Book cover

Verhandlungen der Deutschen Gesellschaft für innere Medizin pp 739–813Cite as

Hepatologie

  • Conference paper

  • 24 Accesses

Part of the book series: Verhandlungen der Deutschen Gesellschaft für innere Medizin ((VDGINNERE,volume 89))

Zusammenfassung

Die chronisch aktive Hepatitis (CAH) ist ein ätiologisch heterogenes Krankheitsbild. Autoantikörper gegen ein mikrosomales Antigen aus Leber und Niere (LKM) scheinen eine Subgruppe der CAH zu charakterisieren (Rizetto et al. 1973, 1974) [1, 2]. In der bisher angewendeten Immunfluoreszenztechnik (IF) an Nierenschnitten können diese Antikörper nur sehr schwer von antimitochondrialen (AMA) und anderen zytoplasmatischen Antikörpern unterschieden werden. Es ist bisher nicht geklärt, ob bei der primär biliären Zirrhose (PBC) zusätzlich zu AMA LKM-Antikörper vorkommen. Mit der Immunfluoreszenz kann ein zusätzliches Auftreten von LKM-Antikörpern nicht differenziert werden. Außerdem stand bisher ein spezifisches serologisches Testsystem nicht zur Verfügung.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Rizetto M, Swana G, Doniach D (1973) Microsomal antibodies in active chronic hepatitis and other disorders. Clin Exp Immunol 15: 331–344

    Google Scholar 

  2. Rizetto M, Bianchi FB, Doniach D (1974) Characterization of the microsomal antigen related to a subclass of active chronic hepatitis. Immunology 26: 589–601

    Google Scholar 

  3. Manns M, Meyer zum Büschenfelde K-H (1982) A mitochondrial antigen — antibody system in cholestatic liver disease detected by radioimmunoassay. Hepatology 2: 1–7

    Article  PubMed  CAS  Google Scholar 

  4. Smith MGM, Williams R, Walker G, Rizetto M, Doniach D (1974) Hepatic disorders associated with liver/kidney microsomal antibodies. Br Med J 2: 80–84

    Article  PubMed  CAS  Google Scholar 

Literatur

  1. Carolla G, Digeon M, Feldmann G, Jungers P, Drouet I, Bach JF (1977) Detection of hepatitis B antigen in circulating immune complexes in acute and chronic hepatitis. Scand J Immunol 6: 1267

    Google Scholar 

  2. Nydegger UE, Lambert PH, Gerber H, Miescher PA (1974) Circulating immune complexes in the serum of systemic lupus erythematodes and carriers of hepatitis B antigen. J Clin Invest 54: 297

    Article  PubMed  CAS  Google Scholar 

  3. Wands IR, Mann E, Alpert E, Isselbacher KI (1975) The pathogenesis of arthritis associated with acute and hepatitis B surface antigen-positive hepatitis. J Clin Invest 55: 930

    Article  PubMed  CAS  Google Scholar 

  4. Thomas HC, De Villiers D, Potter B, Hodgson H, Jain S, Jewell DP, Sherlock S (1978) Immune complexes in acute and chronic liver disease. Clin Exp Immunol 31: 150

    PubMed  CAS  Google Scholar 

Literatur

  • Dienes H et al. (1982) Histologic observations in human hepatitis non-A, non-B. Hepatology 2: 562–571

    Article  PubMed  CAS  Google Scholar 

  • Hütteroth TH et al. (1982) Cellular cytotoxicity against the human hepatoma cell line PLC/PRF/5 in patients with hepatitis B virus-induced chronic active hepatitis (CAH) and non-A, non-B (NANB) CAH. Liver 2: 285–291

    Google Scholar 

  • Meyer zum Büschenfelde K-H et al. (1979) Immunologic liver injury: the role of hepatitis B viral antigens and liver membrane antigens as targets. Prog Liver Dis 6: 407–424

    PubMed  Google Scholar 

  • Vergani GM et al. (1979) Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis. Clin Exp Immunol 38: 16–21

    PubMed  CAS  Google Scholar 

Literatur

  1. Dienstag JL, Bhan AK (1980) Enhanced in vitro cell-mediated cytotoxicity in chronic hepatitis B virus infection: absence of specificity for virus-expressed antigen on target cell membranes. J Immunol 125: 2269–2276

    PubMed  CAS  Google Scholar 

  2. Chisari FV, Bieber MS, Josepho GA, Xavier C, Anderson DS (1981) Functional properties of lymphocyte subpopulations in hepatitis B-virus infection. II. Cytotoxic effector cell killing of targets that naturally express hepatitis B surface antigen and liver specific lipoprotein. J Immunol 126: 45–49

    PubMed  CAS  Google Scholar 

  3. Eddleston ALWF, Mondelli M, Mieli-Vergani G, Williams R (1982) Lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection. Hepatology (Suppl) 2: 122S–127S

    Google Scholar 

  4. James SP, Vierling JM, Strober W (1981) The role of the immune response in the pathogenesis of primary biliary cirrhosis. Semin Liver Dis 1: 322–337

    Article  PubMed  CAS  Google Scholar 

  5. Rieber P, Lohmeyer J, Schendel DJ, Riethmüller G (1981) Human T-cell differentiation antigens characterizing a cytotoxic/suppressor T-cell subset. Hybridoma 11: 59–69

    Article  Google Scholar 

  6. Abo T, Balch CM (1981) A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK1). J Immunol 127: 1024–1029

    PubMed  CAS  Google Scholar 

  7. Koprowski H, Steplewski Z, Herlyn D, Herlyn M (1978) Studies of antibodies against human melanoma produced by somatic cell hybrids. Proc Natl Acad Sci USA 75: 3405–3409

    Article  PubMed  CAS  Google Scholar 

  8. Reinherz EL, Kung PC, Pesando JM, Ritz J, Goldstein G, Schlossman SF (1979) Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression. J Exp Med 150: 1472–1482

    Article  PubMed  CAS  Google Scholar 

  9. Pape GR, Troye M, Perlmann P (1977) Characterization of cytolytic effector cells in peripheral blood of healthy individuals and cancer patients. J Immunol 118: 1919–1924

    PubMed  CAS  Google Scholar 

  10. Pape GR, Rieber EP, Eisenburg J, Hoffmann R, Paumgartner G, Riethmüller G (1983) Involvement of the cytotoxic/suppressor T-cell subset in liver tissue injury of patients with acute and chronic liver dieseases. Gastroenterology (in press)

    Google Scholar 

  11. Dudley FJ, Giustino V, Sherlock S (1972) Cell-mediated immunity in patients positive for hepatitis associated antigen. Br Med J 4: 752–759

    Google Scholar 

  12. Gudat F, Bianchi L, Sonnabend W, Thiel G, Aenishaenstin W, Stalder GA (1975) Pattern of core and surface expression in liver tissue reflects state of specific immune response in hepatitis B. Lab Invest 32: 1–12

    PubMed  CAS  Google Scholar 

  13. Popper H (1975) Clinical pathological correlation in viral hepatitis: The effect of the virus on the liver. Am J Pathol 81: 609–619

    PubMed  CAS  Google Scholar 

  14. Edgington TS, Chisari FV (1975) Immunological aspects of hepatitis B virus infection. Am J Med Sci 270: 213–229

    Article  Google Scholar 

  15. Quinnan GV, Manischewitz JE, Ennis FA (1978) Cytotoxic T lymphocyte response to murine cytomegalovirus infection. Nature 273: 514–515

    Article  Google Scholar 

  16. Quinnan GV, Manischewitz JE (1979) The role of natural killer cells and antibody dependent cell-mediated cytotoxicity during murine cytomegalovirus infection. J Exp Med 150: 1549–1554

    Article  PubMed  CAS  Google Scholar 

  17. Quinnan GV, Kirmani N, Esber E, Saral R, Manischewitz JE, Rogers JL, Rook AH, Santos GW, Burus WH (1981) HLA-restricted cytotoxic T-lymphocyte response to cytomegalovirus infection of bone marrow transplant recipients. J Immunol 126: 2036–2041

    PubMed  Google Scholar 

  18. Quinnan GV, Kirmani N, Rook AH, Manischewitz JE, Jackson L, Moresci G, Santos GW, Saral R, Burus WH (1982) Cytotoxic T-cells in cytomegalovirus infection. HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med 307: 7–13

    Article  PubMed  Google Scholar 

Literatur

  1. Cohen BJ (1978) The IgM antibody response to the core antigen of hepatitis B virus. J Med Virol 3: 141–149

    Article  PubMed  CAS  Google Scholar 

  2. Flehmig B, Ranke M, Berthold H, Gerth HJ (1979) A solid-phase radioimmunoassay for the detection of IgM antibodies to the hepatitis A virus. J Infect Dis 140: 169–175

    Article  PubMed  CAS  Google Scholar 

  3. Gerlich WH, Luer W, Thommsen R (1980) Diagnosis of acute and inapparent hepatitis B virus infections by measurement of IgM antibody to hepatitis B core antigen. J Infect Dis 142: 95–101

    Article  PubMed  CAS  Google Scholar 

  4. Hawkes RA, Boughton CR, Ferguson V, Lehman NI (1980) Use of immunoglobulin M antibody to hepatitis B core antigen in diagnosis of viral hepatitis. J Clin Microbiol 11: 581–583

    PubMed  CAS  Google Scholar 

  5. Hoofnagle JH, Gerety R, Ni L, Barker L (1974) Antibody to hepatitis B core antigen. A sensitive marker of hepatitis B virus replication. N Engl J Med 290: 1336–1340

    Article  PubMed  CAS  Google Scholar 

  6. Huschka U, Maier J, Rauterberg EW, Doerr HW (1982) Rapid separation of immunoglobulin M by affinity chromatography for detection of specific antibodies to rubellae and treponema pallidum. Eur J Clin Microbiol 1: 118–121

    Article  PubMed  CAS  Google Scholar 

  7. Kryger P, Mathiesen LR, Aldershvile J, Nielsen JO (1981) Presence and meaning of anti-HBc-IgM as determined by ELISA in patients with acute type B hepatitis and healthy HBsAg carriers. Hepatology 1: 233–237

    Article  PubMed  CAS  Google Scholar 

  8. Nakane PK, Kawavi A (1974) Peroxydase-labeled antibody. A new method of conjugation. J Histochem Cytochem 22: 1084–1091

    Article  PubMed  CAS  Google Scholar 

  9. Roggendorf M, Deinhardt F,Frösner GG, Scheid R, Bayerl B, Zachoval R (1981) Immunoglobulin M antibodies to hepatitis B core antigen: Evaluation of enzyme immunoassay for diagnosis of hepatitis B virus infection. J Clin Microbiol 13: 618–626

    PubMed  CAS  Google Scholar 

  10. Stahl S, MacKay P, Magazin M, Bruce SA, Murray K (1982) Hepatitis B virus core antigen: synthesis in E. coli and application in diagnosis. Proc Natl Acad Sci USA 79: 1606–1610

    Article  PubMed  CAS  Google Scholar 

  11. Tedder RS, Wilson-Croome R (1980) Detection by radioimmunoassay of IgM class antibody to hepatitis B core antigen: a comparison of two methods. J Med Virol 6: 235–247

    Article  PubMed  CAS  Google Scholar 

Literatur

  1. Berg PA, Baum H (1980) Serology of primary biliary cirrhosis. Semin Immunopathol 3: 355–373

    Article  CAS  Google Scholar 

  2. Berg PA, Klein R, Lindborn-Fotinos J, Klöppel W (1982) The ATPase associated antigen (M2) — a marker antigen for the serological diagnosis of primary biliary cirrhosis. Lancet

    Google Scholar 

  3. Miyachi K, Gupta RC, Dickson ER, Tan EM (1980) Precipitating antibodies to mitochondrial antigens with primary biliary cirrhosis. Clin Exp Immunol 39: 599–606

    PubMed  CAS  Google Scholar 

  4. Lindenborn-Fotinos J, Sayers TJ, Berg PA (1982) Mitochondrial antibodies in primary biliary cirrhosis. VI. Association of the complement fixing antigen with a component of the mitochondrial F1ATPase complex. Clin Exp Immunol 50: 267–274

    PubMed  CAS  Google Scholar 

  5. Schultheiß HP, Klingenberg M (1981) Immunochemical characterization of the adenine nucleotide translocator — an autoantigen in patients with anti-mitochondrial antibodies. Immunobiology 160: 107

    Google Scholar 

  6. Schultheiß HP, Klingenberg M (1981) Der ADP-, ATP-Carrier der Mitochondrien als organspezifisches Antigen bei Autoimmunerkrankungen. Verh Dtsch Ges Inn Med 87: 1145–1150

    Google Scholar 

  7. Schultheiß HP, Klingenberg M (1982) Organ- and conformation specificity of the adenine nucleotide translocator. Second European Bioenergetics Conference reports, pp 471–473

    Google Scholar 

  8. Schultheiß HP, Berg PA, Klingenberg M (1983) The mitochondrial adenine nucleotide translocator is an antigen in primary biliary cirrhosis (PBC). J Clin Exp Immunol (in press)

    Google Scholar 

  9. Schultheiß HP, Berg PA, Klingenberg M (1982) Der Adinin-Nucleotid-Translocator (ANT) als organspezifisches Antigen bei der primär biliären Zirrhose (PBC). Verh Dtsch Ges Inn Med 88: 1052–1057

    Google Scholar 

  10. Klingenberg M (1976) The ADP-ATP carrier in mitochondrial membranes. In: Martonosi A (ed) The enzymes of biological membranes, vol 3. Plenum Publ. Corp., New York, pp 383–438

    Google Scholar 

  11. Klingenberg M (1980) The ADP-ATP translocation in mitochondria, a membrane potential controlled transport. J Membrane Biol 56: 97–105

    Article  CAS  Google Scholar 

  12. Klöppel G, Kirchhof M, Berg PA (1982) Natural course of primary biliary cirrhosis. I. A morphological, clinical and serological analysis of 103 cases. Liver 2: 141 – 151

    PubMed  Google Scholar 

  13. Berg PA, Hornberg JC, Bottazo GF, Doniach D (1981) Clinical significance of mitochondrial antibodies in relation to liver disease. Lancet

    Google Scholar 

  14. Riccio H, Aquila H, Klingenberg M (1975) Solubilization of the carboxyatractylate binding protein from mitochondria. FEBS Lett 56: 129–132

    Article  CAS  Google Scholar 

  15. Riccio H, Aquila H, Klingenberg M (1975) Purification of the carboxyatractylate binding protein from mitochondria. FEBS Lett 56: 133–138

    Article  PubMed  CAS  Google Scholar 

  16. Schultheiß HP, Klingenberg M (1983) Immunoelectrophoretic characterization of the ADP/ATP carrier from heart, kidney and liver. BBA (in press)

    Google Scholar 

  17. Rosenthal JD, Kozaburo H, Notkins AL (1972) Rapid micro-radioimmunoassay for measurement of antiviral antibody. J Immunol 109: 171–173

    PubMed  CAS  Google Scholar 

  18. Zollinger WD, DalrympleJM, Artenstein MS (1976) Analysis of parameters affecting the solid phase radioimmunoassay quantitation of antibody to meningococcal antigens. J Immunol 117: 1788–1798

    PubMed  CAS  Google Scholar 

  19. Kessler SW (1975) Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: Parameters of the interaction of the antibodyantigen complexes with protein A. J Immunol 115: 1617–1624

    PubMed  CAS  Google Scholar 

  20. Palmieri F, Klingenberg M (1979) Direct methods for measuring metabolite transport and distribution in mitochondria. In: Fleischer S, Packer L (eds) Methods in enzymology, vol 56. Academic Press, London, pp 279–301

    Google Scholar 

Literatur

  • Arnheiter H et al. (1982) Adult mouse hepatocytes in primary monolayer culture express genetic resistance to mouse hepatitis virus type 3. J Immunol 129: 1275–1281

    PubMed  CAS  Google Scholar 

  • Engler H et al. (1982) Experimental infection of imbred mice with herpes simplex virus lv. Comparison of interferon production and natural killer cell activity in susceptible and resistant adult mice. Arch Virol 74: 239–247

    Article  PubMed  CAS  Google Scholar 

  • Wisse E et al. (1979) The investigation of sinusiodal cells: A new approach to the study of liver function. In: Popper H, Schaffner F (eds) Progress in liver diseases. Grune and Stratton, New York San Francisco London, p 153

    Google Scholar 

Literatur

  1. Ashwell G, Morell AG (1974) The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol 41: 99–128

    PubMed  CAS  Google Scholar 

  2. Cheung WY (1970) Cyclic 3′5′nucleotide phosphodiesterase. Demonstration of an activator. Biochem Biophys Res Commun 38: 533

    Article  PubMed  CAS  Google Scholar 

  3. Kakiuchi S, Yamazaki R (1970) Calcium dependent phosphodiesterase activity and its activating factor (PAF) from brain. Biochem Biophys Res Commun 41: 1104–1110

    Article  PubMed  CAS  Google Scholar 

  4. Pearse BMF (1975) Coated vesicles from pig brain: Purification and biochemical characterization. J Mol Biol 97: 93

    Article  PubMed  CAS  Google Scholar 

  5. Pearse BMF (1976) Clathrin: A unique protein associated with intracellular transfer of membrane by coated vesicles. Proc Natl Acad Sci USA 73: 1255

    Article  PubMed  CAS  Google Scholar 

  6. Salisbury JL, Condeelis JS, Satir P (1980) Role of coated vesicles, microfilaments, and calmodulin in receptor-mediated endocytosis by cultured B lymphoblastoid cells. J Cell Biol 87: 132–141

    Article  PubMed  CAS  Google Scholar 

  7. Schwartz AL, Fridovich SE, Knowles BB, Lodish HF (1981) Characterization of the asialoglycoprotein receptor in a continuous hepatoma line. J Biol Chem 256: 8878–8881

    PubMed  CAS  Google Scholar 

  8. Teo TS, Wang TH, Wang JH (1973) Purification and properties of the protein activator of bovine heart cyclic adenosine 3′5′ monophosphate. J Biol Chem 248: 588–595

    PubMed  CAS  Google Scholar 

Literatur

  1. Reichen J, Berk PD (1979) Isolation of an organic anion binding protein from rat liver plasma membrane fractions by affinity chromatography. Biochem Biophys Res Commun 91: 484–489

    Article  PubMed  CAS  Google Scholar 

  2. Tiribelli C, Lunazi G, Luciani GL, Panfili E, Gassin B, Liut G, Sandri G, Sottocasa G (1978) Isolation of a sulfobromophthalein-binding protein from hepatocyte plasma membrane. Biochim Biophys Acta 532: 105–112

    PubMed  CAS  Google Scholar 

  3. Wolkoff AW, Chung CT (1980) Identification, purification and partial characterization of an organic anion binding protein from rat liver cell plasma membrane. J Clin Invest 65: 1152–1161

    Article  PubMed  CAS  Google Scholar 

  4. Fisher MM, Boxam DL, Oda M, Phillips MJ, Yousef YM (1975) Characterization of rat liver cell plasma membranes. Proc Soc Exp Biol Med 150: 177–184

    PubMed  CAS  Google Scholar 

  5. Reichen J, Blitzer BL, Berk PD (1981) Binding of unconjugated and conjugated sulfobromophthalein to rat liver plasma membrane fractions in vitro. Biochim Biophys Acta 640: 298–312

    Article  PubMed  CAS  Google Scholar 

  6. Stremmel W, Potter BJ, Berk PD (1983) Studies of albumin binding to rat liver plasma membranes — implications for the albumin receptor hypothesis. Biochim Biophys Acta (in press)

    Google Scholar 

  7. Neville DM (1971) Molecular weight determination of protein-dodecyl sulfate complexes by gel electrophoresis in a discontinuous buffer system. J Biol Chem 246: 6328–6334

    PubMed  CAS  Google Scholar 

  8. Gerber MA, Garfinkel E, Hirschman SZ, Thung SN, Panagiotatos T (1981) Immune and enzyme histochemical studies of a human hepatocellular carcinoma cell line producing hepatitis B surface antigen. J Immunol 126: 1085–1089

    PubMed  CAS  Google Scholar 

  9. Berry NM, Friend DS (1969) High yield preparation of isolated rat liver parenchymal cells. J Cell Biol 43: 506–5020

    Article  PubMed  CAS  Google Scholar 

Literatur

  1. Caesar J, Shaldon S, Chiandussi L, Guevara L, Sherlock S (1961) The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci 21: 43–57

    PubMed  CAS  Google Scholar 

  2. Child CG III (1954) The hepatic circulation and portal hypertension. W. B. Saunders, Philadelphia

    Google Scholar 

  3. Creutzfeldt W, Frerichs H, Sickinger K (1970) Liver diseases and diabetes mellitus. In: Progress in liver disease, vol III. Grune & Stratton, New York London, pp 317–407

    Google Scholar 

  4. Creutzfeldt W, Hartmann H, Nauck M, Stöckmann F (1983) Liver disease and glucose homeostasis. In: Liver in metabolic diseases. MTP Press, Lancaster (in press)

    Google Scholar 

  5. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237 : E214–E223

    Google Scholar 

  6. Greco AV, Bertoli A, Ghirlanda G, Manna R, Altomonte L, Rebuzzi AG (1980) Insulin resistance in liver cirrhosis: decreased insulin binding to circulating monocytes. Horm Metab Res 12: 577–581

    Article  PubMed  CAS  Google Scholar 

  7. Harewood MS, Proietto J, Dudley F, Alford FP (1982) Insulin action and cirrhosis: insulin binding and lipogenesis in isolated adipocytes. Metabolism 31: 1241–1246

    Article  PubMed  CAS  Google Scholar 

  8. Kurz G, Wallenfels K (1974) UV-Test mit Galactose-Dehydrogenase. In: Bergmeyer HU (Hrsg) Methoden der enzymatischen Analyse. Verlag Chemie, Weinheim, S 1324–1333

    Google Scholar 

  9. McGuire, EAH, Helderman JH, Tobin JD, Andres R, Berman M (1976) Effects of arterial versus venous sampling on analysis of glucose kinetics in man

    Google Scholar 

  10. Riggio O, Merli M, Cangiano C, Capocaccia R, Casino A, Lala A, Leonetti F, Mauceri M, Pepe M, Rossi Fanelli F, Savioli M, Tamburrano G, Capocaccia L (1982) Glucose intolerance in liver cirrhosis. Metabolism 31: 627–634

    Article  PubMed  CAS  Google Scholar 

  11. Sherwin RS, Fisher M, Bessoff J, Snyder N, Hendler R, Conn HO, Felig P (1978) Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon. Gastroenterology 74: 1224–1228

    PubMed  CAS  Google Scholar 

  12. Taylor R, Heine R, Collins J, James O, Alberti KGMM (1982) Adipocyte insulin binding, adipocyte insulin sensitivity and insulin resistance in vivo in patients with hepatic cirrhosis. Diabetologia 23: 204

    Article  Google Scholar 

  13. Tygstrup N (1963) Determination of the hepatic galactose elimination capacity in man. Acta Physiol Scand 58: 162–172

    Article  PubMed  CAS  Google Scholar 

Literatur

  1. Keen H, Jarrett RJ, McCartney P (1982) The ten-Year follow up of the Bedord Survey (1962–1972): Glucose tolerance and diabetes. Diabetologia 22: 73–78

    Article  PubMed  CAS  Google Scholar 

  2. Haslbeck M, Silberhorn H, Kraus B, Bachmann W (1980) Prognostic value of OGTT: ten Years follow up of patients with impaired and equivocal glucose tolerance. Diabetologia 19: 281

    Google Scholar 

  3. Creutzfeldt W, Frerichs H, Kraft W (1967) The intravenous tolbutamide test in liver disease. Acta Diabetol Lat (Suppl 1) 4: 205

    Google Scholar 

  4. Oehler G, Bleyl H, Matthes KJ (1982) Hyperinsulinemia in hepatic steatosis. Int J Obesity (Suppl 1) 6: 137–144

    Google Scholar 

  5. Oehler G, Bleyl H, Knecht M, Matthes KJ (1981) Hyperinsulinämie und gestörte Glukosetoleranz bei chronisch-entzündlichen Leberkrankheiten. Z Gastroenterol 19: 26–32

    PubMed  CAS  Google Scholar 

  6. Oehler G, Bleyl H, Matthes KJ (1978) Glukosetoleranz und Insulinsekretion bei Patienten mit chronischen Leberkrankheiten. Med Welt 29: 1314

    PubMed  CAS  Google Scholar 

  7. Neubauer M, Lindemann M, Rosak C, Schalk K, Kaltwasser P, Althoff PH (1982) Störungen von Kohlenhydratstoffwechsel und Endokrinium bei idopathischer Hämochromatose. Inn Med 9: 151–158

    Google Scholar 

  8. Johnston DG, Alberti KGMM, Wright R, Smith-Laing G, Stewart AM, Sherlock S, Faber O, Binder C (1978) C-peptide and insulin in liver disease. Diabetes (Suppl 1) 27:201

    PubMed  CAS  Google Scholar 

  9. Klein B, Morgenstern S, Kaufmann JH (1966) A modified automated ferricyanide-phosphomolybdic acid procedure for serum or plasma glucose. Clin Chem 12: 816

    PubMed  CAS  Google Scholar 

  10. Wide L, Axen R, Porath J (1967) Radioimmunosorbent assay for proteins. Chemical coplings of antibodies to insoluble dextrane. Immunochemistry 4: 381

    Article  CAS  Google Scholar 

  11. Heding LG (1975) Radioimmunological determination of human C-peptide in serum. Diabetologia 11: 541

    Article  PubMed  CAS  Google Scholar 

  12. Keen H, Jarrett RJ, Alberti KGMM (1979) Diabetes mellitus: A new look at diagnostic criteria. Diabetologia 16: 283

    Article  PubMed  CAS  Google Scholar 

  13. Oehler G (1981) Oraler Glukosetoleranztest bei Patienten mit chronischen Leberkrankheiten. Diagnostik 14: 234–238

    Google Scholar 

  14. Köbberling J, Kerlin A, Creutzfeldt W (1980) The reproducibility of the oral glucose tolerance test over long (5 Years) and short periods (1 week). Klin Wochenschr 58: 527

    Article  PubMed  Google Scholar 

  15. Köbberling J, Creutzfeldt W (1970) Comparison of different methods for the evaluation of the oral glucose tolerance test. Diabetes 19:870

    PubMed  Google Scholar 

  16. Otto H (1981) Diabetes mellitus: Labormethoden in Diagnostik und Verlaufskontrolle. Diagnostik 14: 3

    CAS  Google Scholar 

  17. Haslbeck M (1981) Diagnostische Probleme bei Diabetes mellitus. Internist 22: 187

    PubMed  CAS  Google Scholar 

  18. Diabetes Data compiled 1977 (1978) US-Department of Health, Education and Welfare, DHEW Publication No (NIH) 78-1468, US-Government Printing Office, Washington

    Google Scholar 

  19. Ishii H, Mamori H, Takahashi H, Muraoka M, Arai M, Shigeta Y, Saito H, Tsuchiya M (1975) Klinische Untersuchungen zur Pathogenese des hepatogenen Diabetes. Leber Magen Darm 5: 52

    Google Scholar 

Literatur

  1. Rojkind M, Kershenobich D (1981) Hepatic fibrosis. Clin Gastroenterol 10: 737–754

    PubMed  CAS  Google Scholar 

  2. Frei A et al. (1982) Serum procollagen-III-aminopeptide as index of liver fibrosis — new morphometric evidence. Hepatology 2: 733

    Google Scholar 

  3. Savolainen et al. (1983) Enzymes of collagen synthesis and type-III-procollagen aminopropeptide in the evaluation of D-penicillamine and medroxyprogesterone treatments of primary billiary cirrhosis. Gut 24: 136–142

    Article  PubMed  CAS  Google Scholar 

  4. Raedsch R et al. (1982) Prokollagen-Typ-III-Peptid-Serum-konzentrationen bei Patienten mit chronisch persistierender und chronisch aktiver Hepatitis und Leberzirrhose und ihre diagnostische Wertigkeit. Z Gastroenterol 20: 703–709

    Google Scholar 

  5. Rohde H et al. (1979) Radioimmunoassay for type III procollagen peptide and its application to human liver disease. Eur J Clin Invest 9: 451–459

    Article  PubMed  CAS  Google Scholar 

Literatur

  1. Rohde H, Vargas L, Hahn E, Kalbfleisch H, Bruguera M, Timpl R (1979) Radioimmunoassay for type III-procollagen-peptide and its application to human liver disease. Eur J Clin Invest 9: 451–459

    Article  PubMed  CAS  Google Scholar 

  2. Raedsch R, Stiehl A, Waldherr R, Mall G, Gmelin K, Götz R, Walker S, Czygan P, Kommerell B (1982) Procollagen-type III-peptide serum concentrations in chronic persistent and chronic active hepatitis and in cirrhosis of the liver and their diagnostic value. Z Gastroenterol 20: 738–743

    PubMed  CAS  Google Scholar 

  3. Rubin E, Schaffner F, Popper H (1965) Primary biliary cirrhosis. Chronic non-suppurative destructive cholangitis. Am J Pathol 46: 387–407

    PubMed  CAS  Google Scholar 

Literatur

  1. Denckla WD, Dewey HK (1967) The determination of tryptophan in plasma, liver and urine. J Lab Clin Med 69: 1188–1197

    Google Scholar 

  2. James H, Ziparo V, Jeppson B, Fischer JE (1979) Hyperammonaemia, plasma amino acid imbalance and bloodbrain amino acid transport: a unified theory of portalsystemic encephalopathy. Lancet 10: 772–775

    Article  Google Scholar 

  3. Rössle M, Herz R, Hiss W, Gerok W (1983) Der Tryptophan-Belastungstest als Funktionsparameter bei Lebererkrankungen. Klin Wochenschr 61: 277–283

    Article  PubMed  Google Scholar 

Literatur

  1. Beasly RP, Lin CC, Hwang LY, Chien CS (1981) Hepatocellular Carcinoma and hepatitis B virus. Lancet 11: 1129–1133

    Article  Google Scholar 

  2. Child CG, Turcotte JG (1964) Surgery and portal hypertension. In: Child CG (ed) The liver and portal hypertension. W.B. Saunders, Philadelphia, pp 50–56

    Google Scholar 

  3. Higgins J (1963) The geographic pathology of primary liver cancer. Cancer Res 23: 1624–1633

    Google Scholar 

  4. Lee FI (1967) Cirrhosis and hepatoma in alcoholics. Gut 7: 77–85

    Article  Google Scholar 

  5. Minar E, Pötzi R, Dragosics B, Hirschl M, Lochs H, Marosi L (1983) Notfallendoskopie bei Patienten mit Leberzirrhose. Leber Magen Darm 13: 21–26

    PubMed  CAS  Google Scholar 

  6. Österreichische Staatsdruckerei (1979) Statistisches Handbuch für die Republik Österreich. Statistisches Zentralamt Wien, S 44–46

    Google Scholar 

  7. Ornata M, Ashcavi H, Choon-Tsek L, Peters RL (1978) Hepatocellular carcinoma in the USA. Etiologic considerations. Gastroenterology 76: 279–287

    Google Scholar 

  8. Shikata T (1976) Primary liver carcinoma and liver cirrhosis. In: Okuda K, Peters RL (eds) Hepatocellular carcinoma. J. Wiley & Sons Inc., New York, pp 63–71

    Google Scholar 

  9. Ugarte G, Donoso S (1978) Primary hepatic tumors in Chile. Remmer H, Bannsch P, Bolt HM, Popper H (eds) Primary liver tumors. MTP Press, Lancaster, pp 165–169

    Google Scholar 

  10. Wewalka F, Hadziyannis St, Pesendorfer FX, Dragosics B, Base W (1979) OMGE Study on prevalence of hepatitis B surface antigen in different liver diseases. Scand J Gastroenterol (Suppl 56) 14: 55–58

    Google Scholar 

Literatur

  • Allison DJ (1978) Therapeutic embolization. Br J Hosp Med 20: 707–715

    PubMed  CAS  Google Scholar 

  • Allison DJ (1982) The nonsurgical management of metastatic endocrine tumors of the liver. In: Wilkins RA, Viamonte M (eds) Interventional radiology. Blackwell Scientific Publ., Oxford London Edinburgh Boston Melbourne, p 191

    Google Scholar 

  • Broder LE, Carter SK (1973) Pancreatic islet-cell carcinoma II: Results of therapy with streptozotocin in 52 patients. Ann Intern Med 79: 108–118

    PubMed  CAS  Google Scholar 

  • Chuang VP, Wallace S (1981) Hepatic artery embolization in the treatment of hepatic neoplasms. Radiology 140: 51–58

    PubMed  CAS  Google Scholar 

  • Chuang VP, Wallace S, Soo CS, Charnsangavej C, Bowers T (1982) Therapeutic ivalon embolization of hepatic tumors. Am J Roentgenol 138: 289–294

    CAS  Google Scholar 

  • Creutzfeldt W (1980) Endocrine tumors of the pancreas: Clinical, chemical and morphological findings. In: Fitzgerald PJ, Morrison AB (eds) The pancreas. Williams & Wilkins, Baltimore London, p 208

    Google Scholar 

  • Friesen SR (1982) Tumors of the endocrine pancreas. N Engl J Med 306: 580–590

    Article  PubMed  CAS  Google Scholar 

  • Gelin LE, Lewis DH, Nilsson L (1968) Liver blood flow in man during abdominal surgery. II: The effect of hepatic artery occlusion on the blood flow through metastatic tumor nodules. Acta Hepatogastroenterol (Stuttg) 15: 21–24

    CAS  Google Scholar 

  • Moertel CG, Hanley JA, Johnson LA (1980) Streptozocin alone with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma. N Engl J Med 303: 1189–1194

    Article  PubMed  CAS  Google Scholar 

  • Spigos DG, Tan WS, Jonasson C (1981) Therapeutic embolization, techniques and clinical application. Surg Annu 13: 362–381

    Google Scholar 

  • Trede M, Raute M (1981) Möglichkeiten der chirurgischen Therapie von Lebermetastasen. Dtsch Med Wochenschr 106: 492–496

    Article  PubMed  CAS  Google Scholar 

Literatur

  • Carr BD, Duncan JG (1976) Liver volume determination by ultrasound: a feasibility study. Br J Radiol 49: 776–778

    Article  PubMed  CAS  Google Scholar 

  • Castell D, O’Brien KD, Muench H et al. (1969) Estimation of liver size in normal individuals. Ann Intern Med 70: 1183–1189

    PubMed  CAS  Google Scholar 

  • DeLand FH, North WA (1968) Relationship between liver size and body size. Radiology 91: 1195–1198

    PubMed  CAS  Google Scholar 

  • Fioroli W (1960) A method for the clinical determination of liver size. Triangle 4: 268–288

    Google Scholar 

  • Gladisch R (1981) Praxis der Ultraschalldiagnostik. Schattauer, Stuttgart New York

    Google Scholar 

  • Holder LE, Strife J, Padikal TN, Perkins PJ, Kerelanes JG (1975) Liver size determination in pediatrics using sonographic and scintigraphic techniques. Radiology 117: 349–353

    PubMed  CAS  Google Scholar 

  • Kardel T, Holm HH, Rasmussen SN, Mortensen T (1971) Ultrasonic determination of liver and spleen volumes. Scand J Clin Lab Invest 27: 123–128

    Article  PubMed  CAS  Google Scholar 

  • Koischwitz D (1979) Sonographische Lebervolumenbestimmung. Problematik, Methodik und praktische Bedeutung der Quantifizierung des Lebervolumens. Fortschr Röntgenstr 131: 243–248

    Article  CAS  Google Scholar 

  • Lutz H, Ehler R, Reichel L, Meyer P (1979) Stellenwert der Ultraschalldiagnostik bei Lebererkrankungen. Klinikarzt 8: 533–541

    Google Scholar 

  • Naftalis J, Leevy CM (1963) Clinical estimation of liver size. Am J Dig Dis 8: 236–243

    Article  PubMed  CAS  Google Scholar 

  • Peternell WW, Schaefer JW, Schifi L (1966) Clinical evaluation of liver size and hepatic scintiscan. Am J Dig Dis 11: 346–350

    Article  Google Scholar 

  • Phaler GE (1926) The measurement of the liver by means of roentgen rays based upon a study of 502 cases. Am J Roentgenol Rad Ther Nucl Med 16: 558–564

    Google Scholar 

  • Rasmussen SN (1978) Liver volume determination by ultrasonic scanning. Dan Med Bull 25: 1–45

    PubMed  CAS  Google Scholar 

  • Sapira JD, Williamson DL (1979) How big is the normal liver? Arch Intern Med 139: 971–973

    Article  PubMed  CAS  Google Scholar 

  • Sullivan S, Krasner N, Williams R (1976) The clinical estimation of liver size: a comparison of techniques and an analysis of the source of error. Br Med J

    Google Scholar 

Literatur

  1. Bartoli E, Massarelli G, Solinas A, Faedda R, Chiandussi L (1979) Acute hepatitis with bridging necrosis due to hydralazine intake. Arch Intern Med 139: 698–699

    Article  PubMed  CAS  Google Scholar 

  2. Enat R, Rader G, Barzilai D (1977) Leberschaden durch Adelphan. Schweiz Med Wochenschr 107: 657–658

    PubMed  CAS  Google Scholar 

  3. Forster HS (1980) Hepatitis from hydralazine. Letter to the editor. N Engl J Med 302: 1362

    PubMed  CAS  Google Scholar 

  4. Itoh S, Ichinoe A, Tsukada Y, Itoh Y (1981) Hydralazine induced hepatitis. Acta Hepatogastroenterol (Stuttg) 28: 13–16

    CAS  Google Scholar 

  5. Jori GP, Peschle C (1973) Hydralazine disease associated with transient granulomas in the liver. Gastroenterology 64: 1163–1167

    PubMed  CAS  Google Scholar 

  6. Knoblauch M, Cueni B, Spycher M, Schmid M (1977) Dihydralazin-induzierte, akute Hepatitis bei IgM-Mangel. Schweiz Med Wochenschr 107: 651–656

    PubMed  CAS  Google Scholar 

  7. Roschlau G, Baumgarten R, Winter H (1982) Hepatitis mit konfluierenden Nekrosen durch Depressan. Dtsch Gesundh Wesen 37: 709–712

    Google Scholar 

Literatur

  1. Allan RN, Thistle JL, Hofmann AF (1976) Lithocholate metabolism during chemotherapy for gallstone dissolution. Gut 17: 413–419

    Article  PubMed  CAS  Google Scholar 

  2. Barnes S, Burhol PG, Zander R, Haggstrom G, Settine RL, Hirschowitz BI (1979) Enzymatic sulfation of glycochenodeoxycholic acid by tissue fractions from adult hamsters. J Lipid Res 20: 952–959

    PubMed  CAS  Google Scholar 

  3. Bedi BS, Debas HT, Gillespie G, Gillespie IE (1971) Effect of bile salts on antral gastrin release. Gastroenterology 60: 256–262

    PubMed  CAS  Google Scholar 

  4. Black RB, Naylor F, Stenhouse NS (1977) Gastric mucosal damage by taurine and glycine conjugates of chenodeoxycholic acid. Am J Dig Dis 22: 1106–1108

    Article  PubMed  CAS  Google Scholar 

  5. Caspary WF (1975) Einfluß von Aspirin, Antacida, Alkohol und Gallensäuren auf die transmurale elektrische Potentialdifferenz des menschlichen Magens. Dtsch Med Wochenschr 100: 1263–1268

    Article  PubMed  CAS  Google Scholar 

  6. Cheli R, Santi L, Ciancamerla G, Canciani G (1973) A clinical and statistical follow-up study of atrophic gastritis. Am J Dig Dis 18: 1061

    Article  PubMed  CAS  Google Scholar 

  7. Classen M, v Hinüber G, Demling L (1968) Disaccharides of the gastric mucosa in chronic atrophic gastritis with intestinal metaplasia. Digestion 1: 52

    Article  PubMed  CAS  Google Scholar 

  8. Cochran KM, Mackenzie JF, Russell RI (1975) Role of taurocholic acid in production of gastric mucosal damage after ingestion of aspirin. Br Med J 1: 183–185

    Article  PubMed  CAS  Google Scholar 

  9. Correa P, Cuello C, Duque E (1970) Carcinoma and intestinal metaplasia of the stomach in Columbian migrants. J Natl Cancer Inst 44: 297

    PubMed  CAS  Google Scholar 

  10. DeBarros SG, Balistieri WF, Soloway RD, Weiss SG, Miller PC, Soper K (1982) Response of total and individual serum bile acids to endogenous and exogenous bile acid input to the enterohepatic circulation. Gastroenterology 82: 647–652

    CAS  Google Scholar 

  11. Eastwood GL (1975) Effect of pH on bile salt injury to mouse gastric mucosa. Gastroenterology 68: 1456–1465

    PubMed  CAS  Google Scholar 

  12. Editorial (1981) Bacteria in the stomach. Lancet 2: 906–907

    Google Scholar 

  13. Fisher MM, Magnusson R, Miyai K (1971) Bile acid metabolism in mammals. I. Bile acid-induced intrahepatic cholestasis. Lab Invest 21: 88–91

    Google Scholar 

  14. Gadacz TR, Allan RN, Mack E, Hofmann AF (1976) Impaired lithocholate sulfation in the rhesus monkey: A mechanism for chenodeoxycholate toxicity. Gastroenterology 70: 1125–1129

    PubMed  CAS  Google Scholar 

  15. Himal HS, Boutros M, Weiser M (1974) The relationship between bile and hydrochloric acid in the pathogenesis of acute gastric erosions. Am J Gastroenterol 62: 405–409

    PubMed  CAS  Google Scholar 

  16. Imai T, Kubo T, Watanabe H (1971) Chronic gastritis in Japanese with reference to high incidence of gastric carcinoma. J Natl Cancer Inst 47: 179

    PubMed  CAS  Google Scholar 

  17. Ivey KJ, Clifton JA, Hubel KA, DenBesten L (1969) Effect of bile salts on back diffusion of hydrogen ions in the human gastric mucosa. J Lab Clin Med 74: 886

    Google Scholar 

  18. Kulkarni M, Barnes S (1981) Lithocholate metabolites are not involved in DNA damage in L1210 cells. Colonic Carcinogenesis Symposium, Titisee, 27.–28.5.81

    Google Scholar 

  19. Kurtz W, Leuschner U, Gemeinhardt S, Classen M (1982) Gallensäuren und ihre Sulphatester in der gesunden Schleimhaut von Magen und Duodenum. Z Gastroenterol 20: 489

    Google Scholar 

  20. Malhotra SL (1976) New approaches to the causation and prevention of cancers of epithelial surfaces. Med Hypotheses 2: 279–281

    Article  PubMed  CAS  Google Scholar 

  21. Norton L, Mathews D, Avrum L, Eiseman B (1974) Pharmacological protection against swine stress ulcer. Gastroenterology 66: 503–508

    PubMed  CAS  Google Scholar 

  22. O’Brien P, Silen W (1973) Effect of bile salts and aspirin on the gastric mucosal blood flow. Gastroenterology 64: 246–253

    PubMed  Google Scholar 

  23. Ponz de Leon M, Carulli N, Loria P, Iori R, Zironi E (1980) Cholesterol absorption during bile acid feeding. Gastroenterology 78: 214–219

    PubMed  CAS  Google Scholar 

  24. Reddy BS, Watanabe K (1979) Effect of cholesterol metabolites and promoting effect of lithocholic acid in colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res 39: 1521–1524

    PubMed  CAS  Google Scholar 

  25. Ritchie WP (1977) Bile acids, the “barrier”, and reflux-related clinical disorders of the gastric mucosa. Surgery 82: 192–200

    PubMed  CAS  Google Scholar 

  26. Safaie-Shirazi S, DenBesten L, Hamza KN (1972) Absorption of bile salts from the gastric mucosa during hemorrhagic shock (36 581). Proc Soc Exp Med Biol 140: 924–927

    CAS  Google Scholar 

Literatur

  • Tserng KY, Klein PD (1977) Synthesis of 13C-labelled bile acids. J Lipid Res 18: 400–408

    PubMed  CAS  Google Scholar 

  • Matern S, Sjövall J, Pomare EW, Heaton KW, Low-Beer TS (1975) Metabolism of deoxycholic acid in man. Med Biol 53: 107–113

    PubMed  CAS  Google Scholar 

Literatur

  • DeWitt EH, Lack L (1980) Effects of sulfation patterns on intestinal transport of bile salt sulfate esters. Am J Physiol 238:G34–G39

    CAS  Google Scholar 

  • Low-Beer TS, Tyor MP, Lack L (1969) Effects of sulfation of taurolithocholic and glycolithocholic acids on their intestinal transport. Gastroenterology 56: 721–726

    CAS  Google Scholar 

Literatur

  1. Kramer W, Buscher H-P, Gerok W, Kurz G (1979) Bile salt binding to serum components. Eur J Biochem 102: 1–9

    Article  PubMed  CAS  Google Scholar 

  2. Middelhoff G, Mordasini R, Stiehl A, Greten (1979) A bile-acid-rich high-density lipoprotein (HDL) in acute hepatitis. Scand J Gastroenterol 14: 267–272

    Article  PubMed  CAS  Google Scholar 

  3. Record CO, Buxton B, Chase RA, Curzon G, Murray-Lyon IM, Williams R (1976) Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest 6: 387–394

    Article  PubMed  CAS  Google Scholar 

Literatur

  1. Balint JA, Beeler DA, Kyriakides EC, Treble DH (1971) The effect of bile salts upon lecithin synthesis. J Lab Clin Med 77: 122–133

    PubMed  CAS  Google Scholar 

  2. Cahlin E, Jösson J, Nilsson S, Schersten T (1972) Synthesis of phospholipids and triglycerides in human liver slices. Scand J Clin Lab Invest 29: 109–114

    Article  PubMed  CAS  Google Scholar 

  3. Isaksson B (1954) On the dissolving power of lecithin and bile salts for cholesterol in human bladder bile. Acta Soc Med Upsal 59: 296–306

    PubMed  CAS  Google Scholar 

  4. Kennedy EP (1962) Biosynthesis of phosphatidylcholine. Harvey Lect 57: 143–171

    Google Scholar 

  5. Lohmann J, Nauen P, Lessing U, Schriewer H, Schönleben K, Clemens M (1980) Eigenschaften der CTP: Cholinphosphat-cytidyltransferase in der mikrosomalen Fraktion menschlicher Leberbiopsien. In: Zelder O, Fischer M, Eckert P, Bode JC (Hrsg) Experimentelle und klinische Hepatologie. Thieme, Stuttgart New York, S 285–290

    Google Scholar 

  6. Schölmerich J, Schmidt K, Kremer B, Becker M-S, Gerok W (1981) Differente Wirkung von Taurolithocholsäure und Chenodesoxycholsäure auf Membranstruktur und Funktion isolierter Hepatozyten. Klin Wochenschr 59: 655–668

    Article  PubMed  Google Scholar 

  7. Vance DE, Choy PC (1979) How is phosphatidylcholine biosynthesis regulated. TIBS July: 145–149

    Google Scholar 

  8. Weinhold PA, Skinner RS, Sanders RD (1973) Activity and some properties of choline kinase, cholinephosphate cytidyltransferase and choline phosphotransferase during liver development in the rat. Biochim Biophys Acta 326: 43–51

    PubMed  CAS  Google Scholar 

Literatur

  1. Best W, Becktel JM, Singleton JM, Kern K (1978) Development of a Crohn’s disease activity index. Gastroenterology 70: 439–444

    Google Scholar 

  2. Hepner GW, Laurence MD (1977) Dynamics of the glycine conjugates of cholic acid, chenodeoxycholic, deoxycholic and sulfolithocholic acid in man. Gastroenterology 72: 499–501

    PubMed  CAS  Google Scholar 

  3. La Russo NF, Hofmann NE, Korman MG, Hofmann AF, Cowen AE (1978) Determinants of fasting and postprandial serum bile acid levels in healthy man. Dig Dis Sci 23: 385–391

    Article  Google Scholar 

  4. Suchy FS, Balistreri WF (1981) Ileal dysfunction in Crohn’s disease assessed by the postprandial bile acid response. Gut 22: 948–982

    Article  PubMed  CAS  Google Scholar 

Literatur

  1. Feely J et al. (1981) Reduction of liver blood flow and propranolol methabolism by cimetidine. N Engl J Med 304: 692–695

    Article  PubMed  CAS  Google Scholar 

  2. Frenzel H et al. (1982) Protective effect of CO2-induced hyperventilation on hepatotoxicity elicited by carbon tetrachloride. Liver 2: 376–384

    PubMed  CAS  Google Scholar 

  3. Kirch W et al. (1982) Der Einfluß von Cimetidin auf die Pharmakokinetik und Pharmakodynamik von Metoprolol. Propranolol und Atenolol. Verh Dtsch Ges Inn Med 88: 659–662

    CAS  Google Scholar 

  4. Klotz V, Reimann J (1980) Delaged clearance of diazepam due to cimetidine. N Engl J Med 302: 1012–1014

    Article  PubMed  CAS  Google Scholar 

  5. Knodell RG (1980) Drug metabolism by rat and human hepatic microsomes in response to interaction with H2-receptor antagonists. Gastroenterology 82: 84–88

    Google Scholar 

  6. Moeschlin S (Hrsg) Tetrachlorkohlenstoff, Tetrachlormethan. In: Klinik und Therapie der Vergiftungen, 6. Aufl. Thieme, Stuttgart New York, S 297–303

    Google Scholar 

  7. Puurunen J, Pelkonen O (1979a) Cimetidine inhibits microsomal drug metabolism in the rat. Eur J Pharmacol 55: 335–336

    Article  PubMed  CAS  Google Scholar 

  8. Puurunen J et al. (1979b) Cimetidine inhibits microsomal drug metabolism in man. Naunyn-Schmiedebergs Arch Pharmacol 308: R24

    Google Scholar 

  9. Recknagel RO (1967) Carbon tetrachloride hepatotoxicity. Pharmacol Rev 19: 145–208

    PubMed  CAS  Google Scholar 

  10. Serlin MJ (1979) Cimetidine. Intoxication with oral anticoagulants in man. Lancet 2: 317–319

    Article  PubMed  CAS  Google Scholar 

  11. Sieger CP et al. (1978) Antihepatotoxic activity of dithiocarb as compared with six other thio compounds in mice. Arch Toxicol (Berl) 41: 79–88

    Article  Google Scholar 

  12. Slater TF (1978) Biochemical studies on liver injury. In: Slater TF (ed) Biochemical mechanisms of liver injury. Academic Press, London, pp 1–44

    Google Scholar 

Literatur

  1. Puurunen J, Sotaniemi E, Pelkonen O (1980) Effect of cimetidine on microsomal drug metabolism in man. Eur J Clin Pharmacol 18: 185–187

    Article  PubMed  CAS  Google Scholar 

  2. Serlin MJ, Mossman S, Sibeon RG, Breckenridge AM, Williams JRB, Atwood JL, Willoughby JMT (1979) Cimetidine: interaction with oral anticoagulants in man. Lancet 2: 317–319

    Article  PubMed  CAS  Google Scholar 

  3. Klotz U, Reimann I (1980) Delayed clearance of diazepam due to cimetidine. N Engl J Med 302: 1012–1014

    Article  PubMed  CAS  Google Scholar 

  4. Desmond PV, Patwardhan RV, Schenker S, Speeg KV Jr (1980) Cimetidine impairs elimination of chlordiazepoxide (Librium) in man. Ann Intern Med 93: 266–268

    PubMed  CAS  Google Scholar 

  5. Neuvonen PJ, Tokola RA, Kaste M (1981) Cimetidine-phenytoin interaction: effect of serum phenytoin concentration and antipyrine test. Eur J Clin Pharmacol 21: 215–220

    Article  PubMed  CAS  Google Scholar 

  6. Knodell RG, Holtzman JL, Crankshaw DL, Steele NM, Stanley LN (1982) Drug metabolism by rat and human hepatic microsomes in response to interaction with H2-receptor antagonists. Gastroenterology 82: 84–88

    PubMed  CAS  Google Scholar 

  7. Desmond PV, Patwardhan R, Parker R, Schenker S, Speeg KV Jr (1980) Effect of cimetidine and other antihistaminics on the elimination of aminopyrine, phenacetin and caffeine. Life Sci 26: 1261–1268

    Article  PubMed  CAS  Google Scholar 

  8. Pelkonen O, Puurunen J (1980) The effect of cimetidine on in vitro and in vivo microsomal drug metabolism in the rat. Biochem Pharmacol 29: 3075–3080

    Article  PubMed  CAS  Google Scholar 

  9. Speeg KV Jr, Patwardhan RV, Avant GR, Mitchell MC, Schenker S (1982) Inhibition of microsomal drug metabolism by histamine H2-receptor antagonists studied in vivo and in vitro in rodents. Gastroenterology 82: 89–96

    PubMed  CAS  Google Scholar 

  10. Drew R, Rowell J, Grygiel J (1981) Cimetidine: a specific inhibitor of hepatic aryl hycrocarbon hydroxylase (AHH) in the rat. Res Commun Chem Pathol Pharmacol 33: 81–93

    PubMed  CAS  Google Scholar 

  11. Henry DA, MacDonald IA, Kitchingman G, Bell GD, Langman MJS (1980) Cimetidine and ranitidine: comparison of effects on hepatic drug metabolism. Br Med J 281: 775–777

    Article  PubMed  CAS  Google Scholar 

  12. Lieber CS, DeCarli LM (1970) Hepatic microsomal ethanol oxidizing system (MEOS): in vitro characteristics and adaptive properties in vivo. J Biol Chem 245: 2505–2512

    PubMed  CAS  Google Scholar 

  13. Salaspuro MP, Lieber CS (1978) Non uniformity of blood ethanol elimination: its exaggeration after chronic consumption. Ann Clin Res 10: 294–297

    PubMed  CAS  Google Scholar 

  14. Lieber CS, DeCarli LM (1970) Quantitative relationship between the amount of dietary fat and the severity of the alcoholic fatty liver. Am J Clin Nutr 23: 474–478

    PubMed  CAS  Google Scholar 

  15. Puurunen J, Pelkonen O (1979) Cimetidine inhibits microsomal drug metabolism in the rat. Eur J Pharmacol 55: 335–336

    Article  PubMed  CAS  Google Scholar 

  16. Lieber CS (1977) Metabolism of ethanol. In: Lieber CS (ed) Metabolic aspects of alcoholism. MTP Press, Lancaster, pp 1–30

    Chapter  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. I. Med. Klinik und Poliklinik Mainz, Deutschland

    M. Manns & K.-H. Meyer zum Büschenfelde

  2. Innere Medizin und Poliklinik, Deutschland

    B. Möller & R. Dominik

  3. Patholog. Inst., Deutschland

    H. Lobeck

  4. Innere Medizin und Poliklinik, Klinikum Charlottenburg, FU Berlin, Deutschland

    U. Hopf

  5. I. Med. Klinik und Poliklinik Mainz, Deutschland

    T. Poralla & T. H. Hütteroth

  6. Med. Klinik II, Klinikum Großhadern und Inst. für Immunologie, Univ. München, Deutschland

    G. R. Pape

  7. Inst. für Immunologie, Univ. München, Deutschland

    E. P. Rieber

  8. Med. Klinik II, Klinikum Großhadern, Univ. München, Deutschland

    J. Eisenburg

  9. Inst. für Immunologie, Univ. München, Deutschland

    R. Hoffmann

  10. Med. Klinik II, Klinikum Großhadern, Univ. München, Deutschland

    G. Paumgartner

  11. Inst. für Immunologie, Univ. München, Deutschland

    G. Riethmüller

  12. Abt. 1.1.4, Med. Univ.-Klinik Heidelberg, Deutschland

    K. Gmelin, G. Hasche & B. Kommerell

  13. Inst. für Virologie, Univ. Heidelberg, Deutschland

    B. Flehmig, G. Sann & H. W. Doerr

  14. Med. Klinik I, Klinikum Großhadern, Univ. München, Deutschland

    H.-P. Schultheiss, P. Schwimmbeck & H.-D. Bolte

  15. Med. Klinik, Univ. Tübingen, Deutschland

    P. A. Berg

  16. Patholog. Inst., Deutschland

    G. Ramadori & H. P. Dienes

  17. Virolog. Abt. des Mikrobiolog. Inst., Univ. Mainz, Deutschland

    D. Falke

  18. Albert-Einstein-College of Medicine, Bronx, New York, USA

    L. Theilmann, Y. R. Stollman, J. L. Salisbury & R. J. Stockert

  19. Med. Klinik D der Med. Einrichtungen, Univ. Düsseldorf, Deutschland

    W. Stremmel

  20. Dept. of Med., Mount Sinai School of Medicine, New York, New York, USA

    S. Kochwa & P. D. Berk

  21. Med. Univ.-Klinik Göttingen, Deutschland

    H. Hartmann, M. Nauck, F. Stöckmann & W. Creutzfeldt

  22. Zentrum für Innere Medizin Gießen, Deutschland

    G. Oehler, M. Büdinger & K. Matthes

  23. Inst. für Klin. Chemie Gießen, Deutschland

    H. Bleyl

  24. Inst. für Klin. Pharmakologie Bern, Deutschland

    K. Weigand

  25. Med. Univ.-Klinik, Heidelberg, Deutschland

    B. Kommerell, R. Raedsch, A. Stiehl, S. Walker, P. Czygan & R. Götz

  26. Med. Univ.-Klinik, Freiburg, Deutschland

    M. Rössle, S. Jäckie, W. Gerok, S. Matera, B. Schumacher, H. Matern & W. Lehnert

  27. I. Med. Univ.-Klinik Wien, Üsterreich

    L. Marosi, C. Pollak & E. Minar

  28. I. Univ.-Klinik für Gastroenterologie und Hepatologie Wien, Üsterreich

    P. Ferenti, B. Dragosics & F. Kiss

  29. Abt. Gastroenterologie und Stoffwechsel, Deutschland

    F. Stöckmann

  30. Abt. Röntgendiagnostik, Deutschland

    J. von Romatowski & R. Schuster

  31. Abt. Gastroenterologie und Stoffwechsel, Med. Univ.-Klinik Göttingen, Deutschland

    W. Creutzfeldt

  32. Med. Klinik D und Poliklinik, Univ. Düsseldorf, Deutschland

    C. Niederau, A. Sonnenberg, J. Müller, W.-P. Fritsch & G. Strohmeyer

  33. Inst. für Blutgerinnungs- und Transfusionswesen, Univ. Düsseldorf, Deutschland

    T. Brüster

  34. Med. Univ.-Poliklinik Heidelberg, Deutschland

    H.-J. Bröker, G. E. Feurle & K.-H. Munderloh

  35. Patholog. Inst., Univ. Würzburg, Deutschland

    H.-W. Altmann

  36. Krankenhaus TABEA, Hamburg, Deutschland

    G. Möckel, W. Hess & G. Gohrband

  37. Abt. Gastroenterologie, Zentrum für Innere Medizin, Univ.-Klinikum Frankfurt, Deutschland

    W. Kurtz, S. Gemeinhardt & M. Classen

  38. Med. Univ.-Klinik und Poliklinik Münster, Deutschland

    J. Lohmann, P. Nauen & H. Schriewer

  39. Chirurg. Univ.-Klinik und Poliklinik Münster, Deutschland

    M. Clemens

  40. Inst. für Pharmakologie und Toxikologie, Univ. des Saarlandes Homburg, Deutschland

    U. Karbach

  41. I. Med. Klinik und Poliklinik, Univ.-Klinik Mainz, Deutschland

    J. Veit & K. Ewe

  42. Zentrum für Innere Medizin am Klinikum, Univ. Gießen, Deutschland

    H.-P. Buscher, M. Beger & J. Homann

  43. Zentrum für Klin. Chemie, Klin. Immunologie und Humangenetik am Inst. für Klin. Chemie und Pathobiochemie, Univ. Gießen, Deutschland

    S. Schneider

  44. Zentrum für Innere Medizin am Klinikum, Univ. Gießen, Deutschland

    S. Rotter

  45. Zentrum für Pathologie am Klinikum, Univ. Gießen, Deutschland

    B. Röttger

  46. Zentrum für Innere Medizin am Klinikum, Univ. Gießen, Deutschland

    F. Kratz

  47. II. Med. Klinik am Klinikum Ingolstadt, Deutschland

    F. Paul

  48. Zentrum für Innere Medizin am Klinikum, Univ. Gießen, Deutschland

    W. Kamenisch & K. J. Matthes

  49. Abt. für Gastroenterologie, Med. Univ.-Klinik Heidelberg, Deutschland

    B. Kommerell, H. K. Seitz & B. Simon

Authors
  1. M. Manns
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K.-H. Meyer zum Büschenfelde
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Möller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Dominik
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Lobeck
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. U. Hopf
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. T. Poralla
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. T. H. Hütteroth
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. G. R. Pape
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. E. P. Rieber
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. J. Eisenburg
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. R. Hoffmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. G. Paumgartner
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. G. Riethmüller
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. K. Gmelin
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. G. Hasche
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. B. Flehmig
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. G. Sann
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. H. W. Doerr
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. B. Kommerell
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. H.-P. Schultheiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. P. Schwimmbeck
    View author publications

    You can also search for this author in PubMed Google Scholar

  23. H.-D. Bolte
    View author publications

    You can also search for this author in PubMed Google Scholar

  24. P. A. Berg
    View author publications

    You can also search for this author in PubMed Google Scholar

  25. G. Ramadori
    View author publications

    You can also search for this author in PubMed Google Scholar

  26. H. P. Dienes
    View author publications

    You can also search for this author in PubMed Google Scholar

  27. D. Falke
    View author publications

    You can also search for this author in PubMed Google Scholar

  28. L. Theilmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  29. Y. R. Stollman
    View author publications

    You can also search for this author in PubMed Google Scholar

  30. J. L. Salisbury
    View author publications

    You can also search for this author in PubMed Google Scholar

  31. R. J. Stockert
    View author publications

    You can also search for this author in PubMed Google Scholar

  32. W. Stremmel
    View author publications

    You can also search for this author in PubMed Google Scholar

  33. S. Kochwa
    View author publications

    You can also search for this author in PubMed Google Scholar

  34. P. D. Berk
    View author publications

    You can also search for this author in PubMed Google Scholar

  35. H. Hartmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  36. M. Nauck
    View author publications

    You can also search for this author in PubMed Google Scholar

  37. F. Stöckmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  38. W. Creutzfeldt
    View author publications

    You can also search for this author in PubMed Google Scholar

  39. G. Oehler
    View author publications

    You can also search for this author in PubMed Google Scholar

  40. H. Bleyl
    View author publications

    You can also search for this author in PubMed Google Scholar

  41. M. Büdinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  42. K. Matthes
    View author publications

    You can also search for this author in PubMed Google Scholar

  43. K. Weigand
    View author publications

    You can also search for this author in PubMed Google Scholar

  44. R. Raedsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  45. A. Stiehl
    View author publications

    You can also search for this author in PubMed Google Scholar

  46. S. Walker
    View author publications

    You can also search for this author in PubMed Google Scholar

  47. P. Czygan
    View author publications

    You can also search for this author in PubMed Google Scholar

  48. M. Rössle
    View author publications

    You can also search for this author in PubMed Google Scholar

  49. S. Jäckie
    View author publications

    You can also search for this author in PubMed Google Scholar

  50. W. Gerok
    View author publications

    You can also search for this author in PubMed Google Scholar

  51. L. Marosi
    View author publications

    You can also search for this author in PubMed Google Scholar

  52. P. Ferenti
    View author publications

    You can also search for this author in PubMed Google Scholar

  53. B. Dragosics
    View author publications

    You can also search for this author in PubMed Google Scholar

  54. F. Kiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  55. C. Pollak
    View author publications

    You can also search for this author in PubMed Google Scholar

  56. E. Minar
    View author publications

    You can also search for this author in PubMed Google Scholar

  57. J. von Romatowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  58. R. Schuster
    View author publications

    You can also search for this author in PubMed Google Scholar

  59. C. Niederau
    View author publications

    You can also search for this author in PubMed Google Scholar

  60. A. Sonnenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  61. J. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  62. W.-P. Fritsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  63. T. Brüster
    View author publications

    You can also search for this author in PubMed Google Scholar

  64. G. Strohmeyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  65. H.-J. Bröker
    View author publications

    You can also search for this author in PubMed Google Scholar

  66. G. E. Feurle
    View author publications

    You can also search for this author in PubMed Google Scholar

  67. K.-H. Munderloh
    View author publications

    You can also search for this author in PubMed Google Scholar

  68. H.-W. Altmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  69. G. Möckel
    View author publications

    You can also search for this author in PubMed Google Scholar

  70. W. Hess
    View author publications

    You can also search for this author in PubMed Google Scholar

  71. G. Gohrband
    View author publications

    You can also search for this author in PubMed Google Scholar

  72. W. Kurtz
    View author publications

    You can also search for this author in PubMed Google Scholar

  73. S. Gemeinhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  74. M. Classen
    View author publications

    You can also search for this author in PubMed Google Scholar

  75. S. Matera
    View author publications

    You can also search for this author in PubMed Google Scholar

  76. B. Schumacher
    View author publications

    You can also search for this author in PubMed Google Scholar

  77. H. Matern
    View author publications

    You can also search for this author in PubMed Google Scholar

  78. W. Lehnert
    View author publications

    You can also search for this author in PubMed Google Scholar

  79. R. Götz
    View author publications

    You can also search for this author in PubMed Google Scholar

  80. H.-P. Buscher
    View author publications

    You can also search for this author in PubMed Google Scholar

  81. M. Beger
    View author publications

    You can also search for this author in PubMed Google Scholar

  82. J. Lohmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  83. P. Nauen
    View author publications

    You can also search for this author in PubMed Google Scholar

  84. H. Schriewer
    View author publications

    You can also search for this author in PubMed Google Scholar

  85. M. Clemens
    View author publications

    You can also search for this author in PubMed Google Scholar

  86. U. Karbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  87. J. Veit
    View author publications

    You can also search for this author in PubMed Google Scholar

  88. K. Ewe
    View author publications

    You can also search for this author in PubMed Google Scholar

  89. J. Homann
    View author publications

    You can also search for this author in PubMed Google Scholar

  90. S. Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  91. S. Rotter
    View author publications

    You can also search for this author in PubMed Google Scholar

  92. B. Röttger
    View author publications

    You can also search for this author in PubMed Google Scholar

  93. F. Kratz
    View author publications

    You can also search for this author in PubMed Google Scholar

  94. F. Paul
    View author publications

    You can also search for this author in PubMed Google Scholar

  95. W. Kamenisch
    View author publications

    You can also search for this author in PubMed Google Scholar

  96. K. J. Matthes
    View author publications

    You can also search for this author in PubMed Google Scholar

  97. H. K. Seitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  98. B. Simon
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Kliniken der Landeshauptstadt Wiesbaden, Wiesbaden, D-6200, Deutschland

    Bernhard Schlegel

Rights and permissions

Reprints and permissions

Copyright information

© 1983 J. F. Bergmann Verlag, München

About this paper

Cite this paper

Manns, M. et al. (1983). Hepatologie. In: Schlegel, B. (eds) Verhandlungen der Deutschen Gesellschaft für innere Medizin. Verhandlungen der Deutschen Gesellschaft für innere Medizin, vol 89. J.F. Bergmann-Verlag. https://doi.org/10.1007/978-3-642-85456-9_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85456-9_16

  • Publisher Name: J.F. Bergmann-Verlag

  • Print ISBN: 978-3-8070-0335-1

  • Online ISBN: 978-3-642-85456-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation